Clinical Trials Logo

Filter by:
NCT ID: NCT05611099 Completed - Sleep Clinical Trials

Robustness and Usability of the Dreem 3 System for at Home Sleep Monitoring in an Insomnia Population.

Start date: August 15, 2022
Phase: N/A
Study type: Interventional

There is an unmet medical need for monitoring sleep for multiple nights in a patient's home, without the inconvenience of traveling and staying overnight in a medical center, and without the need for a technician to set up a polysomnography (PSG) device at the patient's home. Several disorders, and particularly sleep disorders, are associated with insomnia symptoms, and longitudinal sleep assessment may support a better understanding and management of these patients, who currently seldom access sleep lab PSG. On one hand, this study aims at demonstrating whether the final device's user interface supports safe and effective use when being used at home over multiple nights. On the other, the study aims at confirming that stable and consistent data are measured in the device's actual use, for the records to be clinically usable in daily practice.

NCT ID: NCT05611073 Completed - Pseudophakia Clinical Trials

Maximizing Visual Outcomes With Eyhance IOLs

Start date: March 7, 2022
Phase:
Study type: Observational [Patient Registry]

This is a non-interventional prospective, single center, bilateral, non-randomized, open-label, observational clinical study. All patients will have had bilateral implantation of an Eyhance IOL at the time of cataract surgery. These patients will then be compared to assess which patient biometric properties (such as spherical aberration, q value, pupil size, etc.) lead to an overall increase in near or intermediate vision as well as overall patient satisfaction.

NCT ID: NCT05610839 Completed - Clinical trials for AEBT Website Without Check-ins

A RCT of a Fully-automated Self-help AEBT Website

Start date: November 8, 2022
Phase: N/A
Study type: Interventional

Trichotillomania (TTM) is characterized by hair pulling that is repetitive in nature leading to notable hair loss, causing clinically significant distress and resulting in impairments across social and functional domains (APA, 2013). Trichotillomania causes significant social impairment including affecting close relationships, pursuing occupational changes or advancement, or interfering with schooling (Grant et al., 2017; Woods, Flessner, Franklin, Wetterneck, et al., 2006). The core of the treatment of trichotillomania has traditionally been Habit Reversal Training (HRT) (Twohig, Bluett, et al., 2014). Another form of treatment that is gaining empirical support is Acceptance and Commitment Therapy (ACT) which has been studied in four randomized controlled trials, one studying ACT as a standalone treatment (Lee, Homan, et al., 2018), and three examining ACT combined with HRT (Twohig et al., 2021; Lee, Haeger, et al., 2018; Woods, Wetterneck, et al., 2006) which demonstrated efficacy of the combined treatment in decreasing pulling symptom severity. The prevalence of trichotillomania in the US is 1-2% of the population and yet treatment access is limited by many issues including processionals' lack of knowledge of the disorder and low treatment accessibility (Walther et al., 2010). ACT- enhanced behavior therapy has been implemented using telehealth to reach a larger population (42.2% decrease pre-to-post treatment), but telehealth still requires therapist time and incurs notable costs (Lee, Haeger, et al., 2018). The present study aims to address the gap in trichotillomania treatment accessibility by examining the role of check-ins on adherence and efficacy on afully automated, web-based ACT-enhanced HRT treatment for adults with trichotillomania across the United States. We predict that the condition with check-ins will increase adherence and efficacy of the treatment significantly more than the condition without check-ins. Additionally, we predict that hair pulling severity and psychological flexibility will be significantly improved by the condition with check-ins compared to the condition without check-ins.

NCT ID: NCT05610657 Completed - Clinical trials for Moderate Hepatic Impairment

A Pharmacokinetic Study of Mitapivat in Participants With Moderate Hepatic Impairment Compared to Matched Healthy Control Participants With Normal Hepatic Function

Start date: January 10, 2023
Phase: Phase 1
Study type: Interventional

The primary purpose of this study is to compare the pharmacokinetics (PK) of a single oral dose of mitapivat in participants with moderate hepatic impairment to that in matched healthy control participants with normal hepatic function.

NCT ID: NCT05610540 Completed - Cataract Clinical Trials

Patient Preference and Visual Quality With Contralateral Synergy Versus Panoptix

Start date: April 12, 2022
Phase:
Study type: Observational

The goal of this study is to compare the visual quality and patient preference of the Synergy IOL versus the PanOptix IOL when one of each lens is placed in the same patient.

NCT ID: NCT05610514 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Pulmonary and Cardiac Effects of E-Cigarette Use in Pulmonary Patients Who Smoke Cigarettes

Start date: April 28, 2022
Phase: Phase 2
Study type: Interventional

The purpose of this study is to compare the effects of e-cigarettes and continued smoking on pulmonary and cardiac outcomes in a population with established pulmonary disease.

NCT ID: NCT05610449 Completed - COVID-19 Clinical Trials

Assessing Performance of the Testing Done Simple Covid 19 Antigen Test

Start date: November 4, 2022
Phase:
Study type: Observational

This study will measure the sensitivity and specificity of the Testing Done Simple severe acute respiratory syndrome (SARS) CoV-2 antigen test in subjects with suspected Covid-19 that present throughout several urgent care clinics. The antigen test performance will be compared to a real-time polymerase chain reaction (RT-PCR) test.

NCT ID: NCT05610345 Completed - Clinical trials for Postpartum Hemorrhage

The Effect of Placental Cord Drainage on Postpartum Blood Loss

Start date: November 12, 2022
Phase: N/A
Study type: Interventional

To determine if placental cord drainage decreases the blood loss after spontaneous vaginal delivery

NCT ID: NCT05610267 Completed - Ventral Hernia Clinical Trials

Gentrix® Surgical Matrix for Soft Tissue Reinforcement in Ventral Hernia Repair

Start date: November 22, 2022
Phase:
Study type: Observational

The purpose of this study is to collect additional safety data and demonstrate the performance of Integra Gentrix® Surgical Matrix for reinforcement of ventral hernia repairs.

NCT ID: NCT05610189 Completed - Parkinson Disease Clinical Trials

Multiple-dose Trial to Determine the Clinical Bioequivalence Between Tavapadon Tablets in Participants With Parkinson's Disease

Start date: December 15, 2022
Phase: Phase 1
Study type: Interventional

The primary purpose of the study is to evaluate the bioequivalence (BE) of tavapadon 15 milligram (mg) tablet to 3x5 mg tablets in participants with Parkinson's disease.